Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$20,577,126
in 17 filings, $20.2M under 10b5-1 plans

Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-02-27 BRISTOW MICHAEL R Pres. & Chief Executive Offic Grant or award · Stock Option (right to buy) +41,600 41,600
2017-02-16 Grais Linda S Director Grant or award · Stock Option (right to buy) +8,000 8,000
2017-02-16 MITCHELL DANIEL J Director Grant or award · Stock Option (right to buy) +8,000 8,000
2017-02-16 Selby Brian L. VP, Finance Grant or award · Stock Option (right to buy) +23,000 23,000
2017-02-16 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +24,000 24,000
2017-02-16 CONWAY ROBERT E Director Grant or award · Stock Option (right to buy) +8,000 8,000
2017-02-16 BRISTOW MICHAEL R Pres. & Chief Executive Offic Grant or award · Stock Option (right to buy) +42,000 42,000
2017-02-16 Woosley Raymond L. Director Grant or award · Stock Option (right to buy) +8,000 8,000
2017-02-16 Hove Anders D Director Grant or award · Stock Option (right to buy) +10,000 10,000
2017-02-16 Keuer Thomas A Chief Operating Officer Grant or award · Stock Option (right to buy) +25,200 25,200
2016-10-18 Keuer Thomas A Chief Operating Officer Sale −483 $2.45 $1K 14,900
2016-09-20 BRISTOW MICHAEL R Pres. & Chief Executive Offic Sale −1,972 $2.89 $6K 42,638
2016-09-20 Keuer Thomas A Chief Operating Officer Sale −714 $2.89 $2K 15,383
2016-09-20 Ozeroff Christopher David S.V.P., General Counsel Sale −1,185 $2.89 $3K 18,400
2016-09-19 Selby Brian L. VP, Finance Sale −476 $2.91 $1K 2,550
2016-06-09 BRISTOW MICHAEL R Pres. & Chief Executive Offic Grant or award · Stock Option (right to buy) +27,200 27,200
2016-06-09 BRISTOW MICHAEL R Pres. & Chief Executive Offic Grant or award · Stock Option (right to buy) +55,400 55,400
2016-06-09 Keuer Thomas A Chief Operating Officer Grant or award · Stock Option (right to buy) +15,600 15,600
2016-06-09 Keuer Thomas A Chief Operating Officer Grant or award · Stock Option (right to buy) +31,700 31,700
2016-06-09 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +14,800 14,800

Page 22 of 24 · 473 trades